USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 192 filers reported holding USANA HEALTH SCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,558,000 | +14.8% | 74,024 | +12.3% | 0.01% | 0.0% |
| Q2 2020 | $4,841,000 | +4300.9% | 65,933 | +4104.9% | 0.01% | – |
| Q1 2020 | $110,000 | +7.8% | 1,568 | +20.6% | 0.00% | – |
| Q4 2019 | $102,000 | -98.9% | 1,300 | -99.1% | 0.00% | -100.0% |
| Q3 2019 | $9,506,000 | -43.7% | 137,400 | -35.3% | 0.02% | -45.2% |
| Q2 2019 | $16,878,000 | +168.1% | 212,492 | +183.1% | 0.03% | +181.8% |
| Q1 2019 | $6,296,000 | -27.6% | 75,062 | +1.6% | 0.01% | -31.2% |
| Q4 2018 | $8,699,000 | -2.7% | 73,892 | -0.4% | 0.02% | +6.7% |
| Q3 2018 | $8,943,000 | -44.3% | 74,178 | -46.5% | 0.02% | -46.4% |
| Q2 2018 | $16,047,000 | -43.9% | 138,694 | -58.4% | 0.03% | -44.0% |
| Q1 2018 | $28,610,000 | -22.0% | 333,058 | -32.8% | 0.05% | -16.7% |
| Q4 2017 | $36,698,000 | +24.1% | 495,576 | -3.4% | 0.06% | +17.6% |
| Q3 2017 | $29,565,000 | -19.5% | 513,276 | -10.3% | 0.05% | -22.7% |
| Q2 2017 | $36,734,000 | -40.0% | 572,186 | -45.5% | 0.07% | +20.0% |
| Q1 2017 | $61,236,000 | +75.4% | 1,049,476 | +84.0% | 0.06% | -17.9% |
| Q4 2016 | $34,903,000 | -14.0% | 570,316 | +94.5% | 0.07% | -11.8% |
| Q3 2016 | $40,564,000 | -0.7% | 293,197 | -20.0% | 0.08% | -7.3% |
| Q2 2016 | $40,862,000 | -6.7% | 366,702 | +0.1% | 0.08% | -9.9% |
| Q1 2016 | $43,803,000 | +23.3% | 366,220 | +31.7% | 0.09% | +24.7% |
| Q4 2015 | $35,530,000 | +189.6% | 278,120 | +203.9% | 0.07% | +180.8% |
| Q3 2015 | $12,268,000 | -26.4% | 91,529 | -23.6% | 0.03% | -21.2% |
| Q2 2015 | $16,666,000 | -57.0% | 119,836 | -65.6% | 0.03% | -56.6% |
| Q1 2015 | $38,780,000 | +4.5% | 348,178 | -3.7% | 0.08% | +4.1% |
| Q4 2014 | $37,111,000 | -99.9% | 361,736 | -0.2% | 0.07% | +102.8% |
| Q3 2014 | $26,709,190,000 | -2.2% | 362,601 | +3.7% | 0.04% | +5.9% |
| Q2 2014 | $27,310,008,000 | +3.0% | 349,501 | -0.7% | 0.03% | +13.3% |
| Q1 2014 | $26,519,755,000 | -3.2% | 352,001 | -2.9% | 0.03% | -11.8% |
| Q4 2013 | $27,400,471,000 | -9.1% | 362,536 | +4.3% | 0.03% | -53.4% |
| Q3 2013 | $30,153,970,000 | +3.5% | 347,436 | -13.7% | 0.07% | -5.2% |
| Q2 2013 | $29,142,794,000 | – | 402,636 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |